Search bioRxivSearch

EXPLORE CONNECTIONS

An engineered receptor-binding domain improves the immunogenicity of multivalent SARS-CoV-2 vaccines

Follow the relationships that help you find your next source.

Connections are not prepared for this record yet, or its source metadata has changed. The original record remains available while background snapshots are rebuilt.